ID

44356

Description

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT02288208

Lien

https://clinicaltrials.gov/show/NCT02288208

Mots-clés

Versions (2)
  1. 28/01/2020 28/01/2020 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis B NCT02288208

Anglais

Eligibility Hepatitis B NCT02288208

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented history of chronic hepatitis b infection currently being treated with tenofovir or entecavir for at least 3 months
Description

Hepatitis B, Chronic | Tenofovir | entecavir

Type de données

boolean

Alias
UMLS CUI [1]
C0524909
UMLS CUI [2]
C0384228
UMLS CUI [3]
C0971023
measurable titer of hbsag
Description

Hepatitis B Surface Antigens Titer Measurable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C0475208
UMLS CUI [1,3]
C1513040
hbv dna level < 2 log copies/ml or 10² copies/ml
Description

Hepatitis B DNA Measurement

Type de données

boolean

Alias
UMLS CUI [1]
C3641250
no more than child-pugh score of 5 plus a valid fibroscan® of at least 10 readings with a median score of <7 and interquartile range of < 30%
Description

Child-Pugh Clinical Classification | Fibroscan | Score Median | Interquartile Range

Type de données

boolean

Alias
UMLS CUI [1]
C4050412
UMLS CUI [2]
C4522043
UMLS CUI [3,1]
C0449820
UMLS CUI [3,2]
C2939193
UMLS CUI [4]
C1711350
adequate liver function, aspartate ast and alt ≤2 x uln
Description

Liver function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
adequate renal function as evidenced by creatinine ≤2 mg/dl
Description

Renal function | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
participation in any interventional study within 4 weeks prior to screening
Description

Study Subject Participation Status | Interventional Study

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C3274035
known hiv infection, hepatitis c, or other significant hepatic disorder including cirrhosis (child-pugh class b or c)
Description

HIV Infection | Hepatitis C | Liver disease | Liver Cirrhosis Child-Pugh Classification

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0023895
UMLS CUI [4,1]
C0023890
UMLS CUI [4,2]
C4050412
serious illness or autoimmune disease or other known liver disease
Description

Illness Serious | Autoimmune Disease | Liver diseases

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0004364
UMLS CUI [3]
C0023895
uncontrolled hypertension
Description

Uncontrolled hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
impaired cardiac function, uncontrolled cardiac arrhythmias despite medications, or clinically significant cardiac disease
Description

Decreased cardiac function | Cardiac Arrhythmia Uncontrolled | Pharmacotherapy | Heart Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0232166
UMLS CUI [2,1]
C0003811
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0013216
UMLS CUI [4]
C0018799
currently breast feeding, pregnant or planning on becoming pregnant
Description

Breast Feeding | Pregnancy | Pregnancy, Planned

Type de données

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0032992
known allergy or hypersensitivity to any of the formulation components of birinapant or placebo, including citric acid
Description

Hypersensitivity Birinapant Component | Hypersensitivity Placebo Component | Hypersensitivity Citric Acid

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3658709
UMLS CUI [1,3]
C1705248
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0032042
UMLS CUI [2,3]
C1705248
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0055819
history of cranial nerve palsy
Description

Cranial nerve palsy

Type de données

boolean

Alias
UMLS CUI [1]
C0151311
current treatment with anti-tnf therapies or has received treatment with anti-tnf therapies within the last 6 months
Description

Anti-tumor necrosis factor therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0281481
use of non-steroidal anti-inflammatory drugs
Description

Anti-Inflammatory Agents, Non-Steroidal

Type de données

boolean

Alias
UMLS CUI [1]
C0003211
Retour au début de la page

Similar models

Eligibility Hepatitis B NCT02288208

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis B, Chronic | Tenofovir | entecavir
Item
documented history of chronic hepatitis b infection currently being treated with tenofovir or entecavir for at least 3 months
boolean
C0524909 (UMLS CUI [1])
C0384228 (UMLS CUI [2])
C0971023 (UMLS CUI [3])
Hepatitis B Surface Antigens Titer Measurable
Item
measurable titer of hbsag
boolean
C0019168 (UMLS CUI [1,1])
C0475208 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
Hepatitis B DNA Measurement
Item
hbv dna level < 2 log copies/ml or 10² copies/ml
boolean
C3641250 (UMLS CUI [1])
Child-Pugh Clinical Classification | Fibroscan | Score Median | Interquartile Range
Item
no more than child-pugh score of 5 plus a valid fibroscan® of at least 10 readings with a median score of <7 and interquartile range of < 30%
boolean
C4050412 (UMLS CUI [1])
C4522043 (UMLS CUI [2])
C0449820 (UMLS CUI [3,1])
C2939193 (UMLS CUI [3,2])
C1711350 (UMLS CUI [4])
Liver function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
adequate liver function, aspartate ast and alt ≤2 x uln
boolean
C0232741 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Renal function | Creatinine measurement, serum
Item
adequate renal function as evidenced by creatinine ≤2 mg/dl
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status | Interventional Study
Item
participation in any interventional study within 4 weeks prior to screening
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
HIV Infection | Hepatitis C | Liver disease | Liver Cirrhosis Child-Pugh Classification
Item
known hiv infection, hepatitis c, or other significant hepatic disorder including cirrhosis (child-pugh class b or c)
boolean
C0019693 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0023890 (UMLS CUI [4,1])
C4050412 (UMLS CUI [4,2])
Illness Serious | Autoimmune Disease | Liver diseases
Item
serious illness or autoimmune disease or other known liver disease
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0004364 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Decreased cardiac function | Cardiac Arrhythmia Uncontrolled | Pharmacotherapy | Heart Disease
Item
impaired cardiac function, uncontrolled cardiac arrhythmias despite medications, or clinically significant cardiac disease
boolean
C0232166 (UMLS CUI [1])
C0003811 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0013216 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
Breast Feeding | Pregnancy | Pregnancy, Planned
Item
currently breast feeding, pregnant or planning on becoming pregnant
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Hypersensitivity Birinapant Component | Hypersensitivity Placebo Component | Hypersensitivity Citric Acid
Item
known allergy or hypersensitivity to any of the formulation components of birinapant or placebo, including citric acid
boolean
C0020517 (UMLS CUI [1,1])
C3658709 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0032042 (UMLS CUI [2,2])
C1705248 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0055819 (UMLS CUI [3,2])
Cranial nerve palsy
Item
history of cranial nerve palsy
boolean
C0151311 (UMLS CUI [1])
Anti-tumor necrosis factor therapy
Item
current treatment with anti-tnf therapies or has received treatment with anti-tnf therapies within the last 6 months
boolean
C0281481 (UMLS CUI [1])
Anti-Inflammatory Agents, Non-Steroidal
Item
use of non-steroidal anti-inflammatory drugs
boolean
C0003211 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial